Effect of Evobrutinib, a Bruton's Tyrosine Kinase Inhibitor, on Patient-Reported Vitality and Mental Health in Patients with Relapsing Multiple Sclerosis in a Phase 2 Trial
Titel:
Effect of Evobrutinib, a Bruton's Tyrosine Kinase Inhibitor, on Patient-Reported Vitality and Mental Health in Patients with Relapsing Multiple Sclerosis in a Phase 2 Trial
Auteur:
Vermersch, Patrick Giovannoni, Gavin Wolinsky, Jerry Arnold, Douglas L. Kamudoni, Paul Meier, Daniela Piani Thangavelu, Karthinathan Kinkolykh, Anastasiia Hyvert, Yann Tomic, Davorka Montalban, Xavier